Page last updated: 2024-11-03

propranolol and Central Nervous System Neoplasms

propranolol has been researched along with Central Nervous System Neoplasms in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Central Nervous System Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Oldenburg, J1
Malinverno, M1
Globisch, MA1
Maderna, C1
Corada, M1
Orsenigo, F1
Conze, LL1
Rorsman, C1
Sundell, V1
Arce, M1
Smith, RO1
Yau, ACY1
Billström, GH1
Mägi, CÖ1
Beznoussenko, GV1
Mironov, AA1
Fernando, D1
Daniel, G1
Olivari, D1
Fumagalli, F1
Lampugnani, MG1
Dejana, E1
Magnusson, PU1
Filippidis, AS1
Fountas, KN1
Kalani, MY1
Zabramski, JM1
Spetzler, RF1

Other Studies

2 other studies available for propranolol and Central Nervous System Neoplasms

ArticleYear
Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations: A Preclinical Study.
    Stroke, 2021, Volume: 52, Issue:4

    Topics: Animals; Central Nervous System Neoplasms; Disease Models, Animal; Female; Hemangioma, Cavernous, Ce

2021
Letter by Filippidis et al regarding article, "Evaluating strategies for the treatment of cerebral cavernous malformations".
    Stroke, 2011, Volume: 42, Issue:5

    Topics: Adrenergic Antagonists; Central Nervous System Neoplasms; Central Nervous System Vascular Malformati

2011